Prevalence and Determinants of Hospital‐Acquired Infections in Intensive Care Units Before and After the COVID‐19 Pandemic: A Retrospective Descriptive Surveillance Study at a Tertiary Care Hospital in Iran Authors: Shahla Shahbazi, Saeed Mohammadi, Niloofar Heidari, Mohammad Amin Rezaei, Maria Shirvani Published: 2026 ABSTRACT ABSTRACTBackground and AimsHospital‐acquired infections (HAIs) in intensive care units (ICUs) cause significant morbidity, mortality, and costs. The COVID‐19 pandemic intensified infection control, but its effect on HAI prevalence and patterns is unclear. This study compared HAI prevalence, types, and causative agents in an Iranian tertiary hospital before and after COVID‐19.MethodsA retrospective descriptive‐analytical study was conducted on ICU patients admitted to Taleghani Hospital, Kermanshah, Iran, between 2019 and 2020. Demographic, clinical, and microbiological data were collected from hospital records. Associations between categorical variables were assessed using Chi‐square or Fisher's exact tests, and continuous non‐normally distributed variables were compared using the Mann–Whitney U test, with p < 0.05 considered statistically significant.ResultsAmong 1778 ICU admissions, 301 cases of HAIs were identified, yielding an overall prevalence of 16.9%. The prevalence decreased from 131/718 (18.2%) in 2019 to 170/1060 (16.0%) in 2020. Gram‐negative aerobic bacteria were the predominant pathogens in both years (128/131 [97.7%] vs. 163/170 [95.9%]), while fungal and other infections emerged only in 2020. Ventilator‐associated events (VAE) were the most frequent infection type, followed by pneumonia, urinary tract infections (UTIs), surgical site infections (SSIs), and bloodstream infections (BSIs). While VAE and pneumonia decreased in 2020, UTIs and BSIs increased. ICU2 consistently reported the highest infection rates, whereas ICU3 experienced a marked rise in infections in 2020. Statistical analysis confirmed significant associations between infection occurrence and gender, ICU ward, and Gram‐negative bacterial infections (p < 0.05).ConclusionDespite strengthened infection control during COVID‐19, HAIs particularly Gram‐negative infections and VAE remain prevalent in ICUs. Continuous surveillance and targeted interventions are essential to reduce their burden.Keywords: COVID‐19, gram‐negative bacteria, hospital‐acquired infections, infection control, intensive care units Introduction Hospital‐acquired infections (HAIs), are infections occurring on or after the third day of hospital admission, not present at admission [1]. They are a major global health concern, causing significant morbidity, mortality, and increased hospital costs, particularly in intensive care units (ICUs) [2]. The most common HAIs include surgical site infections, urinary tract infections, pneumonia, and bloodstream infection [1]. ICU patients are especially at risk due to critical illness, invasive devices, and immunosuppression [1]. HAIs in ICUs prolong hospital stay, drive antimicrobial resistance, and increase healthcare burdens, though up to one‐third may be preventable with strict infection control [1, 3]. Reported ICU HAI rates vary globally from 20% to 49% and in terms of income level, lower‐middle‐income countries showed a prevalence of 35%, while high‐income countries had a lower prevalence of 26% [4]. The emergence of the coronavirus disease 2019 (COVID‐19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), profoundly altered global healthcare practices [5, 6]. Since its initial identification in Wuhan, China, in late 2019, the virus has spread worldwide, resulting in more than 755 million confirmed cases and over 6.8 million deaths by early 2023 [7]. The first officially reported cases of COVID‐19 in Iran occurred on February 19, 2020 [1], followed by rapid nationwide spread. Kermanshah Province experienced three waves of COVID‐19 between February 20, 2020 and February 19, 2021, based on hospitalization and in‐hospital mortality rates. The first wave occurred from early March to early May, with peak daily admissions and deaths of 189 and 6 cases, respectively. The second and third waves peaked in late May and early September, with maximum daily admissions of 488 and 1244 and corresponding deaths of 16 and 38 cases, respectively [8]. During this period, Taleghani Hospital in Kermanshah managed COVID‐19 patients and allocated specific ICU beds for their care. To mitigate transmission, hospitals implemented stringent infection control strategies, including enhanced use of personal protective equipment (PPE), intensified environmental disinfection, reorganization of wards, and widespread adoption of standard precautions such as safe injection practices and hand hygiene [9]. These interventions not only aimed to control viral spread but also had potential implications for the incidence and patterns of HAIs. Despite strengthened preventive measures, critically ill COVID‐19 patients remained at high risk for secondary bacterial and fungal infections due to prolonged hospitalization, immunosuppressive therapies, and extensive use of invasive devices [9]. The pandemic's impact on HAI epidemiology is complex and contradictory: while some studies have documented a decline in infection rates in certain hospital wards, others have reported increased rates, possibly linked to resource strain and higher patient acuity during pandemic peaks. Given these inconsistencies, further investigation is needed to better understand patterns of HAIs in specific healthcare settings. This study provides real‐world surveillance data from three ICUs in Taleghani Hospital, Kermanshah, Iran, a region under‐represented in the international literature. By comparing ward‐level HAI prevalence, infection types, and causative microorganisms across 2019 (pre‐pandemic) and 2020 (pandemic onset), this study offers context‐specific insights relevant to local infection prevention, control planning, and empiric antimicrobial decision‐making in similar resource‐limited ICU settings. Materials and Methods Study Design and Population This retrospective descriptive‐analytical study was conducted on all patients admitted to the intensive care units (ICU1, ICU2, and ICU3) of Taleghani Hospital, Kermanshah, Iran, between 2019 and 2020. The inclusion criterion was ICU hospitalization during the study period; patients discharged from the ICU before data collection were excluded. Demographic, clinical, and microbiological data were extracted from hospital medical records. Definitions of Hospital‐Acquired Infections (HAIs) HAIs were classified retrospectively based on definitions adapted from CDC/NHSN 2021 to match the data available in hospital records for 2019–2020. Operational definitions were applied for the following infection types: Ventilator‐associated events (VAE): Any respiratory infection occurring > 48 h after initiation of mechanical ventilation. Pneumonia (PNEU): Radiologically confirmed lung infection with clinical signs and positive microbiology ≥ 48 h after ICU admission. Urinary tract infection (UTI): Symptomatic infection in patients with indwelling urinary catheters > 48 h, confirmed by culture. Surgical site infection (SSI): Infection occurring within 30 days after surgery, involving the incision or deeper tissues. Bloodstream infection (BSI): Laboratory‐confirmed bacteremia/fungemia occurring ≥ 48 h after ICU admission, excluding single positive cultures considered contamination. Polymicrobial infections were recorded as separate infection types but counted once per patient in the overall prevalence analysis. Cultures with suspected contamination or colonization (particularly blood and urine cultures without clinical symptoms) were excluded from the analysis. Counting and Metrics Each HAI was counted per patient, not per episode or per isolate. Device‐associated denominators (e.g., ventilator‐days or catheter‐days) were not consistently available due to retrospective data limitations; therefore, rates are reported per patient rather than per 1000 device‐days. For descriptive purposes, median time from ICU admission to infection and from device insertion to infection was calculated. Ethical Considerations This study was approved by the Ethics Committee of Kermanshah University of Medical Sciences (approval code: IR.KUMS.MED.REC.1401.026). All patient information was kept confidential, and data were anonymized before analysis. The study adhered to ethical standards, and results are reported in aggregated form, without identifying any individual patients. Patients had provided informed consent for the use of their anonymized data for research purposes at the time of hospital admission. Statistical Analysis Statistical analyzes were performed using IBM SPSS Statistics for Windows, version 27.0 (IBM Corp., Armonk, NY, USA). Continuous variables with normal distributions were summarized using mean and standard deviation (SD), while non‐normally distributed continuous variables were reported as median and interquartile range (IQR). Categorical variables were described using frequencies and percentages. Given the retrospective, surveillance‐based, and census nature of the study, the primary analytical approach was descriptive. Comparisons between study years (2019 vs. 2020) for categorical variables were assessed using the chi‐square test or Fisher's exact test, as appropriate, to evaluate overall differences in distribution across categories. All statistical tests were two‐sided, and a p‐value < 0.05 was considered statistically significant. To complement descriptive comparisons and to provide interpretable measures of effect with associated uncertainty, absolute risk differences (RDs) between study years were calculated for key categorical outcomes and are reported alongside 95% confidence intervals (CIs). These effect size estimates were intended to descriptively quantify the magnitude and direction of observed differences rather than to support row‐specific hypothesis testing or causal inference. Results Prevalence of Hospital‐Acquired Infections During the 2‐year study period (2019–2020), a total of 1778 patients were admitted to the three intensive care units (ICU1, ICU2, and ICU3) of Taleghani Hospital, Kermanshah, Iran. Of these, 301 patients developed HAIs, yielding an overall prevalence rate of 16.9%. In 2019, among 718 ICU admissions, 131 patients (18.2%) acquired HAIs, while in 2020, 170 infections were identified among 1060 admissions (16.0%). Thus, the prevalence of infections declined slightly in 2020 compared with 2019. Baseline Characteristics Baseline characteristics of patients with hospital‐acquired infections in 2019 and 2020 are presented in Table 1. The median age of infected patients was similar between the two study years (47.0 [IQR: 30.0–65.0] in 2019 vs. 46.0 [IQR: 30.0–65.0] in 2020; Mann–Whitney U test, p = 0.972). Gender distribution was also comparable between years, with males accounting for 84.7% of cases in 2019% and 82.9% in 2020 (Fisher's exact test, p = 0.676). Table 1Baseline demographic and infection‐related characteristics of patients with hospital‐acquired infections in 2019 and 2020.Characteristic20192020 p‐valueb N = 131 a N = 170a Age47.00 (30.00, 65.00)46.00 (30.00, 65.00)0.972Gender0.676Male111 (84.7%)141 (82.9%)Female20 (15.3%)29 (17.1%)Time from ICU admission to infection11.00 (5.00, 37.00)15.00 (6.00, 32.00)0.216Device insertion to infection10.00 (4.00, 29.00)13.00 (5.00, 30.00)0.328Abbreviations: ICU, intensive care unit; N, total number of infected patients. a n (%); Median (Q1 = 25th percentile; Q3 = 75th percentile). b Fisher's exact test; Mann Whitney. Baseline demographic and infection‐related characteristics of patients with hospital‐acquired infections in 2019 and 2020. Abbreviations: ICU, intensive care unit; N, total number of infected patients. n (%); Median (Q1 = 25th percentile; Q3 = 75th percentile). Fisher's exact test; Mann Whitney. In addition, temporal indicators of infection exposure did not differ significantly between cohorts. The median time from ICU admission to infection was 11.0 days (IQR: 5.0–37.0) in 2019 and 15.0 days (IQR: 6.0–32.0) in 2020 (p = 0.216). Similarly, among device‐associated infections, the median time from device insertion to infection was 10.0 days (IQR: 4.0–29.0) in 2019 compared with 13.0 days (IQR: 5.0–30.0) in 2020 (p = 0.328). Gender‐Based Distribution of Hospital‐Acquired Infections When stratified by gender, the overall distribution of infection types differed significantly between 2019 and 2020 among male patients (Fisher's exact test, p = 0.034), whereas no statistically significant change in the overall distribution was observed among female patients (p = 0.359) (Table 2). Across both study years, a consistent predominance of male patients among those with hospital‐acquired infections was observed. Table 2Distribution of hospital‐acquired infections by gender among ICU patients.GenderInfection type2019 (n, %)2020 (n, %) p‐value a RD (95% CI), %MaleVAE60 (54.1%)73 (51.8%)0.034−2.3 (‐14.7, +10.1)PNEU32 (28.8%)27 (19.1%)−9.7 (‐20.3, +1.0)UTI7 (6.3%)17 (12.1%)+5.8 (‐1.3, +12.8)SSI11 (9.9%)12 (8.5%)−1.4 (‐8.6, +5.8)BSI1 (0.9%)7 (5.0%)+4.1 (+ 0.1, +8.1)Other infections0 (0%)5 (3.5%)+3.5 (+ 0.5, +6.6)FemaleVAE12 (60.0%)12 (41.4%)0.359−18.6 (‐46.6, +9.3)PNEU3 (15.0%)4 (13.8%)−1.2 (‐21.3, +18.9)UTI3 (15.0%)11 (37.9%)+22.9 (‐0.7, +46.5)SSI2 (10.0%)2 (6.9%)−3.1 (‐19.2, +13.0)BSI0 (0%)0 (0%)—Other infections0 (0%)0 (0%)—Abbreviations: BSI, bloodstream infection; CI, confidence interval; n, total number of infected patients in each gender for the corresponding year (2019: n = 131; 2020: n = 170); PNEU, pneumonia; RD, risk difference; SSI, surgical site infection; UTI, urinary tract infection; VAE, ventilator‐associated events. a Fisher exact test. Distribution of hospital‐acquired infections by gender among ICU patients. Abbreviations: BSI, bloodstream infection; CI, confidence interval; n, total number of infected patients in each gender for the corresponding year (2019: n = 131; 2020: n = 170); PNEU, pneumonia; RD, risk difference; SSI, surgical site infection; UTI, urinary tract infection; VAE, ventilator‐associated events. Fisher exact test. A descriptive comparison of infection patterns by gender revealed several temporal trends. Among male patients, the proportion of ventilator‐associated events (VAE) showed a slight decrease from 54.1% in 2019% to 51.8% in 2020, corresponding to a risk difference (RD) of −2.3% (95% CI: −14.7 to +10.1). Pneumonia also declined among males from 28.8% to 19.1% (RD: −9.7%, 95% CI: −20.3 to +1.0), while urinary tract infections (UTIs) increased from 6.3% to 12.1% (RD: +5.8%, 95% CI: −1.3 to +12.8). Surgical site infections (SSIs) showed a modest decrease (9.9% to 8.5%; RD: −1.4%, 95% CI: −8.6 to +5.8). In contrast, bloodstream infections (BSIs) increased from 0.9% in 2019% to 5.0% in 2020 (RD: +4.1%, 95% CI: +0.1 to +8.1), and other infection types were observed only among male patients in 2020 (3.5%; RD: +3.5%, 95% CI: +0.5 to +6.6). Among female patients, larger relative changes were observed, although accompanied by wide confidence intervals reflecting smaller sample sizes. The proportion of VAE decreased from 60.0% in 2019% to 41.4% in 2020 (RD: −18.6%, 95% CI: −46.6 to +9.3). UTIs increased from 15.0% to 37.9% (RD: +22.9%, 95% CI: −0.7 to +46.5), whereas pneumonia (15.0% to 13.8%; RD: −1.2%, 95% CI: −21.3 to +18.9) and SSIs (10.0% to 6.9%; RD: −3.1%, 95% CI: −19.2 to +13.0) showed minimal changes. No bloodstream or other infection types were observed among female patients in either study year. Distribution of Causative Organisms in Hospital‐Acquired Infections Analysis of causative organisms showed that gram‐negative aerobes were the predominant pathogens associated with healthcare‑associated infections in both study years. When comparing 2019 and 2020, the overall distribution of infection types attributed to gram‑negative organisms differed at the distributional level (Fisher's exact test, p = 0.022), indicating a change in the composition of infection categories over time (Table 3). In contrast, the distribution of infection types caused by gram‑positive aerobes remained largely unchanged between the 2 years (p = 0.709). Table 3Distribution of healthcare‐associated infections by causative organisms (2019–2020).Infection type2019 (n, %)2020 (n, %) p‐valuea RD (95% CI), %Gram‐negative aerobesVAE70 (54.7%)82 (50.3%)0.022−4.4 (− 15.8, +7.0)PNEU35 (27.3%)31 (19%)−8.3 (− 17.9, +1.3)UTI10 (7.8%)25 (15.3%)+7.5 (− 0.1, +15.1)SSI12 (9.4%)13 (8%)−1.4 (− 8.1, +5.3)BSI1 (0.8%)7 (4.3%)+3.5 (+ 0.1, +6.9)Other0 (0%)5 (3.1%)+3.1 (+ 0.3, +5.9)Gram‐positive aerobesVAE2 (66.7%)1 (50%)0.709−16.7 (− 74.3, +40.9)PNEU0 (0%)0 (0%)—UTI0 (0%)0 (0%)—SSI1 (33.3%)1 (50%)+16.7 (− 40.9, +74.3)BSI0 (0%)0 (0%)—Other0 (0%)0 (0%)—FungiVAE00_—PNEU0—UTI03 (100%)+100.0 (+ 100.0, +100.0)SSI00—BSI00—Other00—Unidentified organismsVAE02 (100%)_+100.0 (+ 100.0, +100.0)PNEU00—UTI00—SSI00—BSI00—Other00—Abbreviations: BSI, bloodstream infection; CI, confidence interval; n, total number of infections caused by the corresponding organism group in each year (2019: n = 131; 2020: n = 170); PNEU, pneumonia; RD, risk difference; SSI, surgical site infection; UTI, urinary tract infection; VAE, ventilator‐associated events. a Fisher exact test. Distribution of healthcare‐associated infections by causative organisms (2019–2020). Abbreviations: BSI, bloodstream infection; CI, confidence interval; n, total number of infections caused by the corresponding organism group in each year (2019: n = 131; 2020: n = 170); PNEU, pneumonia; RD, risk difference; SSI, surgical site infection; UTI, urinary tract infection; VAE, ventilator‐associated events. Fisher exact test. A descriptive examination of gram‑negative infections revealed several temporal patterns. VAE remained the most common infection type in both years, although their relative frequency decreased slightly from 54.7% in 2019% to 50.3% in 2020 (RD: −4.4%, 95% CI: −15.8 to +7.0). A similar downward pattern was observed for pneumonia, which declined from 27.3% to 19.0% (RD: −8.3%, 95% CI: −17.9 to +1.3). In contrast, urinary tract infections increased from 7.8% to 15.3% (RD: +7.5%, 95% CI: −0.1 to +15.1), and bloodstream infections rose from 0.8% in 2019% to 4.3% in 2020 (RD: +3.5%, 95% CI: +0.1 to +6.9). Surgical site infections showed only a small decrease over time (9.4% to 8.0%; RD: −1.4%, 95% CI: −8.1 to +5.3), while other infection types were reported exclusively in 2020 (3.1%; RD: +3.1%, 95% CI: +0.3 to +5.9). Infections caused by gram‑positive aerobes were uncommon in both years and were largely limited to ventilator‑associated events and surgical site infections, with no clear temporal variation observed. Fungal infections were identified only in 2020 and were exclusively associated with urinary tract infections. Similarly, infections attributed to unidentified organisms were reported only in 2020, primarily in association with ventilator‑associated events. Given the very small number of cases in these categories, findings related to gram‑positive aerobes, fungal infections, and unidentified organisms are presented descriptively to illustrate observed patterns rather than to support formal comparisons. Incidence of Hospital‐Acquired Infections Across Different ICU Wards The distribution of hospital‑acquired infections across ICU wards is shown in Table 4. ICU2 accounted for the largest share of infections in both study years, comprising 42.0% of cases in 2019% and 41.8% in 2020. ICU1 contributed a smaller proportion of infections over time, decreasing from 33.6% in 2019% to 20.0% in 2020, whereas ICU3 demonstrated a relative increase, with the proportion of infections rising from 24.4% to 38.2% in 2020. Table 4Descriptive data and association of hospital‐acquired infections (2019‐2020) by ICU ward.ICUInfection type2019 (n, %)2020 (n, %) p‐valuea RD (95% CI), %ICU1VAE28 (63.6%)18 (52.9%)0.11−10.7 (− 33.4, +12.0)PNEU9 (20.5%)5 (14.7%)−5.8 (− 23.5, +11.9)UTI2 (4.5%)7 (20.6%)+16.1 (+ 1.0, +31.2)SSI5 (11.4%)2 (5.9%)−5.5 (− 18.5, +7.5)BSI0 (0%)1 (2.9%)+2.9 (− 2.8, +8.6)Other0 (0%)1 (2.9%)+2.9 (− 2.8, +8.6)ICU2VAE25 (45.5%)35 (49.3%)0.653+3.8 (− 13.9, +21.5)PNEU18 (32.7%)16 (22.5%)−10.2 (− 26.2, +5.8)UTI5 (9.1%)11 (15.5%)+6.4 (− 4.9, +17.7)SSI6 (10.9%)7 (9.9%)−1.0 (− 12.6, +10.6)BSI1 (1.8%)2 (2.8%)+1.0 (− 3.8, +5.8)Other0 (0%)0 (0%)_ICU3VAE19 (59.4%)32 (49.2%)0.393−10.2 (− 31.4, +11.0)PNEU8 (25%)10 (15.4%)−9.6 (− 26.4, +7.2)UTI3 (9.4%)10 (15.4%)+6.0 (− 6.8, +18.8)SSI2 (6.3%)5 (7.7%)+1.4 (− 8.7, +11.5)BSI0 (0%)4 (6.2%)+6.2 (+ 0.3, +12.1)Other0 (0%)4 (6.2%)+6.2 (+ 0.3, +12.1)Abbreviations: BSI, bloodstream infection; CI, confidence interval; ICU, intensive care unit; n, total number of infections reported in the corresponding ICU during each year (2019 or 2020); PNEU, pneumonia; RD, risk difference; SSI, surgical site infection; UTI, urinary tract infection; VAE, ventilator‐associated events. a Fisher exact test; Chi square test. Descriptive data and association of hospital‐acquired infections (2019‐2020) by ICU ward. Abbreviations: BSI, bloodstream infection; CI, confidence interval; ICU, intensive care unit; n, total number of infections reported in the corresponding ICU during each year (2019 or 2020); PNEU, pneumonia; RD, risk difference; SSI, surgical site infection; UTI, urinary tract infection; VAE, ventilator‐associated events. Fisher exact test; Chi square test. Within individual ICUs, descriptive comparisons revealed heterogeneous temporal patterns in infection types. In ICU1, ventilator‑associated events (VAE) remained the most frequent infection category, although their proportion declined from 63.6% in 2019% to 52.9% in 2020 (RD: −10.7%, 95% CI: −33.4 to +12.0). Pneumonia showed a similar decrease (20.5% to 14.7%; RD: −5.8%, 95% CI: −23.5 to +11.9), while urinary tract infections increased notably from 4.5% to 20.6% (RD: +16.1%, 95% CI: +1.0 to +31.2). Surgical site infections declined modestly (11.4% to 5.9%), and bloodstream and other infection types were observed only in 2020. In ICU2, the overall pattern of infections remained relatively stable across the 2 years (Fisher's exact test, p = 0.653). VAE continued to be the most common infection type, with a slight increase from 45.5% to 49.3% (RD: +3.8%, 95% CI: −13.9 to +21.5). Pneumonia declined from 32.7% to 22.5% (RD: −10.2%, 95% CI: −26.2 to +5.8), whereas UTIs increased from 9.1% to 15.5% (RD: +6.4%, 95% CI: −4.9 to +17.7). Surgical site and bloodstream infections showed minimal variation, and no other infection types were recorded in this ICU during the study period. Types of Infections Analysis of infection types among ICU patients indicated that ventilator‑associated events (VAE) were the most prevalent hospital‑acquired infections in both study years, followed by pneumonia (PNEU), urinary tract infections (UTI), surgical site infections (SSI), and bloodstream infections (BSI) (Figure 1). At the distributional level, the overall composition of infection types differed between 2019 and 2020 (Fisher's exact test, p = 0.011), indicating a change in the relative contribution of specific infection categories over time (Table 5). Prevalence of hospital‐acquired infections by infection type in ICU patients during 2019 and 2020. Data are presented as percentages of total infections for each year. Infection types include ventilator‐associated events (VAE), pneumonia (PNEU), urinary tract infections (UTI), surgical site infections (SSI), bloodstream infections (BSI), and other infections. Blue bars represent prevalence in 2019, and green bars represent prevalence in 2020. Table 5Distribution and risk difference of hospital‐acquired infection types in 2019 and 2020.Infection type2019 (n, %)2020 (n, %) p‐valuea RD (95% CI), %VAE72 (55.0%)85 (50.0%)0.011−5.0 (−16.3, 6.4)PNEU35 (36.7%)31 (18.2%)−8.5 (−18.0, 1.1)UTI10 (7.6%)28 (16.5%)+8.8 (+ 1.6, +16.0)SSI13 (9.9%)14 (8.2%)−1.7 (−8.3, +4.9)BSI1 (0.8%)7 (4.1%)+3.4 (0.0, +6.7)Other0 (0%)5 (2.9%)+2.9 (0.4, +5.5)Abbreviations: BSI, bloodstream infection; CI, confidence interval; n, total number of infections of each type in the corresponding year. Percentages are calculated relative to the total number of hospital‐acquired infections in that year (2019: n = 131; 2020: n = 170); PNEU, pneumonia; RD, risk difference; SSI, surgical site infection; UTI, urinary tract infection; VAE, ventilator‐associated events. a Fisher exact test. Distribution and risk difference of hospital‐acquired infection types in 2019 and 2020. Abbreviations: BSI, bloodstream infection; CI, confidence interval; n, total number of infections of each type in the corresponding year. Percentages are calculated relative to the total number of hospital‐acquired infections in that year (2019: n = 131; 2020: n = 170); PNEU, pneumonia; RD, risk difference; SSI, surgical site infection; UTI, urinary tract infection; VAE, ventilator‐associated events. Fisher exact test. A descriptive year‑to‑year comparison revealed several notable temporal patterns. The proportion of VAE declined modestly from 55.0% in 2019% to 50.0% in 2020 (RD: −5.0%, 95% CI: −16.3 to +6.4), accompanied by a more pronounced reduction in pneumonia, which decreased from 36.7% to 18.2% (RD: −8.5%, 95% CI: −18.0 to +1.1). In contrast, urinary tract infections increased from 7.6% to 16.5% (RD: +8.8%, 95% CI: +1.6 to +16.0), and bloodstream infections rose from 0.8% in 2019% to 4.1% in 2020 (RD: +3.4%, 95% CI: 0.0 to +6.7). Surgical site infections showed only a small decrease over the study period (9.9% to 8.2%; RD: −1.7%, 95% CI: −8.3 to +4.9). Notably, additional infection categories including skin and soft tissue infections, surgical incision site infections, and central nervous system infections were reported exclusively in 2020, accounting for 2.9% of all infections (RD: +2.9%, 95% CI: +0.4 to +5.5). These findings suggest a shift in the overall infection pattern in 2020 compared with 2019. Discussion This study investigated the prevalence and patterns of HAIs among patients admitted to the ICUs of Taleghani Hospital in Kermanshah during 2019–2020, encompassing 1778 ICU admissions, of which 301 patients developed HAIs (16.92%). Our overall ICU HAI prevalence is higher than reported in European ICUs for 2019, where 7.4% of patients staying > 2 days developed at least one ICU‐acquired HAI, including pneumonia (4%), bloodstream infection (3%), and urinary tract infection (2%). In comparison, Iranian national surveillance data for the same period reported an overall HAI prevalence of 26.57 per 1000 patients, with device‐related infections and urinary tract infections being the most common [10]. These comparisons suggest that our ICU HAI rates are within the range observed nationally, but higher than European averages, reflecting regional differences in ICU patient populations, resource availability, and infection control practices. Regarding infection types, ventilator‐associated infections and pneumonia were predominant in 2019 (55% and 26.7%, respectively) and declined in 2020 (50% and 18.2%), while urinary tract infections and bloodstream infections increased in 2020 (16.5% and 4.1%, respectively). The overall moderate decline in ventilator‐associated infections and pneumonia in 2020 may be attributed to intensified infection prevention measures implemented during the COVID‐19 pandemic, although urinary tract and bloodstream infections increased, possibly due to increased device use and ICU workload. During the COVID‐19 pandemic, substantial shifts in ICU infection patterns were reported. In Italy, ventilator‐associated lower respiratory tract infections increased sharply among COVID‐19 patients compared with 2019 (from 0% to 38%) [11]. Likewise, in Swiss ICUs, HAI incidence in COVID‐19 patients was 49.1 per 1000 patient‐days compared with 22.5 in non‐COVID‐19 patients, mainly driven by pulmonary infections. Together, these findings highlight the substantial impact of COVID‐19‐related ICU reorganization on infection epidemiology, although the direction of change differed across settings. A recent study conducted in China comparing HAI prevalence before and after the COVID‐19 outbreak reported a significant reduction in overall infections during 2020 (1.39%) compared to 2019 (2.56%), alongside decreases in mortality and critical cases, although this reduction was not observed in ICU patients [12]. In contrast, our data from Taleghani Hospital ICUs showed a slight decrease in HAI prevalence post‐COVID (from 18.24% in 2019% to 16.03% in 2020). Another study in southeast Iran observed a 31%–100% reduction in HAIs during the COVID‐19 pandemic in critical care units, except for bloodstream infections, which increased by 40% [13]. Furthermore, intensified infection control measures during the COVID‐19 pandemic have been linked to reductions in certain HAIs; however, some units, including ICUs, experienced stable or increased HAI rates due to challenges such as staff shortages and resource limitations [14]. Microbiological analysis revealed that Gram‐negative bacteria were dominant in both years. In our study, the distribution of infection types caused by Gram‐negative organisms changed significantly between 2019 and 2020 (p = 0.022), with a relative decline in ventilator‐associated events and pneumonia and an increase in urinary tract and bloodstream infections. These findings mirror global and regional studies emphasizing the predominance of Gram‐negative bacilli in ICU infections. Similar pathogen distributions were reported in Iranian ICUs [15], European settings, and COVID‐19 ICU patients [16]. In summary, our findings indicate a moderate decline in HAI prevalence in ICUs following the COVID‐19 outbreak, with shifting patterns in infection types and causative organisms. These results underscore the importance of continuous infection surveillance and tailored preventive strategies in critical care settings, especially under pandemic conditions. Conclusion This study demonstrates that hospital‐acquired infections remain a substantial challenge in ICUs at Taleghani Hospital before and after the COVID‐19 pandemic, despite a modest overall decline in prevalence and shifts in infection types and causative microorganisms. Our findings demonstrate the critical need for sustained infection control measures, continuous surveillance, and targeted interventions tailored to evolving infection patterns, particularly in the context of global health crises such as COVID‐19. The observed decrease in ventilator‐associated infections and pneumonia alongside increases in urinary tract and bloodstream infections highlights the dynamic nature of ICU infection epidemiology. Moreover, the predominance of aerobic Gram‐negative bacteria and the observed gender‐ and age‐related differences in infection rates underscore the importance of strengthening infection prevention strategies and optimizing resource allocation to reduce HAIs and improve patient outcomes. Limitations This study has several limitations. First, key clinical variables such as severity of illness scores (e.g., SOFA), immunosuppressive therapy, and detailed mechanical ventilation status were not available, which may affect HAI risk and complicate interpretation of differences between years and ICU wards. Second, device exposure data (e.g., patient‐days, ventilator‐days, catheter‐days, central line‐days) were not consistently recorded, preventing calculation of standardized incidence rates, device‐associated infection rates, or device utilization ratios. Consequently, all infection rates are reported per patient, limiting direct comparability with other studies. Third, while demographic variables, comorbidities, ICU type, length of stay, and device placement were included, the absence of additional exposure and clinical parameters limits full control for case‐mix differences. Small numbers in some infection categories also restricted formal hypothesis testing. Therefore, findings are presented descriptively as absolute risk differences with 95% confidence intervals, emphasizing temporal trends rather than statistical significance or causal inference. Future prospective studies with comprehensive clinical and device‐use data are needed to validate these findings and improve internal and external validity. Author Contributions Shahla Shahbazi contributed to conceptualization, methodology, and writing – review and editing. Saeed Mohammadi contributed to data analysis and writing – review and editing. Niloofar Heidari contributed to data curation, formal analysis, visualization, and writing the original draft. Mohammad Amin Rezaei contributed to investigation, data curation, resources, and writing the original draft. Maria Shirvani contributed to conceptualization, methodology, project administration, validation, supervision, and writing – review and editing, and served as the corresponding author. Conflicts of Interest The authors declare no conflicts of interest. Transparency Statement All authors have read and approved the final version of the article. Maria Shirvani had full access to all of the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis. Maria Shirvani affirms that this article is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.